Table 5.

Multivariate Competing Risk Analysis of Predictors of Wait-list Removal for Improvement

Predictor variables	Sub HR (95 % CI)	P Value
ALD (vs non-ALD)
At 6 months after listing*	1.06 (0.89–1.26)	0.496
At 1 year after listing*	1.49 (1.30–1.69)	< 0.001
At 2 years after listing*	2.91 (2.35–3.61)	< 0.001
Age (vs 18–34)
35–49	0.70 (0.58–0.84)	< 0.001
50–64	0.57 (0.48–0.68)	< 0.001
65 and older	0.84 (0.68–1.03)	0.10
Female Sex	1.33 (1.19–1.47)	< 0.001
BMI (vs 20–29)
Less than 20	1.30 (1.02–1.65)	0.04
30–34	0.73 (0.63–0.84)	< 0.001
35–39	0.81 (0.67–0.98)	0.03
> or = 40	0.79 (0.59–1.06)	0.11
Blood group (vs AB)
A	1.41 (1.03–1.94)	0.03
B	1.45 (1.03–2.03)	0.03
O	1.40 (1.02–1.92)	0.04
Ascites (vs Absent)
Slight	0.43 (0.37–0.48)	< 0.001
Moderate or more	0.15 (0.12–0.20)	< 0.001
Spontaneous bacterial peritonitis	0.84 (0.64–1.11)	0.23
Encephalopathy (vs none)
Grade 1–2	0.42 (0.36–0.48)	< 0.001
Grade 3–4	0.13 (0.07–0.22)	< 0.001
Diabetes	0.83 (0.72–0.95)	0.007
MELD at listing (vs < 15)
15–24	0.62 (0.54–0.70)	< 0.001
25–34	0.74 (0.60–0.92)	0.006
≥ 35	0.72 (0.53–0.99)	0.04
Region for listing, by grouping of wait-time (vs short)
Moderate	0.84 (0.74–0.95)	0.007
Long	0.64 (0.55–0.74)	< 0.001
Cohort (vs 2002–2006)
2007–2011	2.12 (1.82–2.47)	< 0.001
2012–2016	3.07 (2.64–3.57)	< 0.001

^*Significant interaction between alcoholic liver disease and time since listing was identified (p < 0.001). Therefore, subhazard ratios are reported at 6 months, 1 year, and 2 years after listing.